Savaria Q4 2025 Adjusted EBITDA Reaches $51.3M, an increase of 19.7%

Go back to Savaria Q4 2025 Adjusted EBITDA Reaches $51.3M, an increase of 19.7%
Isis Pharmaceuticals, Inc. (NASDAQ: SIS) Delayed: 5.00 +0.08 (1.63%)
Previous Close $4.92    52 Week High $5.09 
Open $4.95    52 Week Low $4.75 
Day High $5.09    P/E N/A 
Day Low $4.75    EPS $-1.63 
Volume 70,734